In our prospective , randomised , double-blind , placebo-controlled , parallel-group study , we enrolled patients aged @-@ years with moderate-to-severe COPD ( post-bronchodilator forced expiratory volume in @ s -LSB- FEV@ -RSB- / forced vital capacity < @ and FEV@ of @-@ % of predicted ) at @ hospitals in China .